| Synonyms: | |
| Status: | Approved (2016) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | J05AP11 |
| UNII: | 8YE81R1X1J |
| InChI Key | RXSARIJMSJWJLZ-CIAYNJNFSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C38H52N6O10S |
| Molecular Weight | 784.93 |
| AlogP | 3.3 |
| Hydrogen Bond Acceptor | 11.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 195.22 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 54.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Hepatitis C virus serine protease, NS3/NS4A inhibitor | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
Serine protease S29 regulatory subfamily
|
- | 0-2 | - | 0 | 99 | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
|
- | 0-2 | - | 0 | 99 | |
|
Enzyme
Protease
Serine protease
|
- | 0-12 | - | 0 | 99 | |
|
Unclassified protein
|
- | - | - | 0-12 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis C, Chronic | 4 | D019698 | ClinicalTrials |
| Hepatitis C | 3 | D006526 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1350514-68-9 |
| ChEBI | 132975 |
| ChEMBL | CHEMBL2063090 |
| DrugBank | DB11575 |
| DrugCentral | 5081 |
| EPA CompTox | DTXSID50159234 |
| FDA SRS | 8YE81R1X1J |
| PDB | SUE |
| PharmGKB | PA166163437 |
| PubChem | 71576667 |
| SureChEMBL | SCHEMBL2175313 |
| ZINC | ZINC000095551509 |
| CAS NUMBER | 1350514-68-9 |
| ChEMBL | CHEMBL3039533 |
| EPA CompTox | DTXSID00159229 |
| FDA SRS | 4O2AB118LA |
| PubChem | 71576667 |
| SureChEMBL | SCHEMBL18259662 |